Have fewer maybes with OCREVUS

Proven in relapsing MS

OCREVUS was proven in 2 large, identical clinical studies against REBIF®*:

  • Shown to reduce relapses
  • Shown to slow disability progression
  • Impact to brain lesions
  • Safety information from clinical studies

OCREVUS was compared to REBIF, an active treatment currently approved for relapsing MS, not a placebo. A placebo is a substance or treatment that has no active medicine.

Learn more about relapsing MS and OCREVUS by downloading a patient education kit.

See how OCREVUS was studied in relapsing MS

OCREVUS was studied against a currently approved treatment for relapsing MS

OCREVUS was compared to REBIF, an active treatment currently approved for relapsing MS, not a placebo. A placebo is a substance or treatment that has no active medicine.

Proven in PPMS

OCREVUS is the first and only approved treatment for PPMS:

  • Shown to slow disability progression
  • Impact in walking speed
  • Results in brain lesion volume
  • Safety information from a clinical study

OCREVUS was evaluated in a study including 732 people. People were treated with OCREVUS or placebo for at least 120 weeks.

Learn more about PPMS and OCREVUS by downloading a patient education kit.

See how OCREVUS was studied in PPMS

OCREVUS was studied in a range of people who had PPMS

Why was OCREVUS compared with a placebo in PPMS?

OCREVUS was studied against a placebo. A placebo is a substance or treatment that has no active medicine. It is common for a treatment to be compared with a placebo when there are no existing approved treatments to compare it with.
Since OCREVUS is the first and only treatment approved for PPMS, it was not possible to measure it against another approved treatment.

OCREVUS is given once every 6 months

*REBIF® is a registered trademark of EMD Serono, Inc.
First dose of OCREVUS is split—given as 2 separate infusions 2 weeks apart.

Talk to your doctor about OCREVUS

Discover information and resources that can help you make the most of your next doctor's appointment.

Concerned about paying for OCREVUS?

There may be options to help you afford OCREVUS, no matter what type of health insurance you have.